本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

CERo Therapeutics Holdings, Inc.

9.26
-0.2000-2.11%
盘后9.22-0.0400-0.43%16:48 EDT
成交量:5.68万
成交额:53.06万
市值:477.91万
市盈率:0.00
高:9.57
开:9.35
低:9.22
收:9.46
数据加载中...
2025/01/27

SEC问询函

Form CORRESP - Correspondence
2025/01/21

重要事件披露

Form 8-K - Current report
2025/01/21

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/10

重要事件披露

Form 8-K - Current report
2025/01/07

重要事件披露

Form 8-K - Current report
2025/01/06

重要事件披露

Form 8-K - Current report
2024/12/31

重要事件披露

Form 8-K - Current report
2024/12/23

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/12/13

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/12/06

重要事件披露

Form 8-K - Current report
2024/12/04

SEC问询函

Form CORRESP - Correspondence
2024/12/04

SEC问询函

Form CORRESP - Correspondence
2024/11/27

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/11/25

SEC问询函

Form CORRESP - Correspondence
2024/11/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/11/20

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/20

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/20

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/19

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]